• Naloxone Hydrochloride: Beyond Antagonism in Stem Cell and I

  2026-05-27

  Explore how Naloxone hydrochloride, a leading opioid receptor antagonist, advances neural stem cell research and immune modulation. This article uncovers unique receptor-dependent and independent mechanisms, offering new perspectives for innovative assay design.

• Substance P: Applied Workflows for Pain and Inflammation Res

  2026-05-27

  Substance P, a benchmark tachykinin neuropeptide, enables advanced modeling of pain transmission, neuroinflammation, and immune response modulation. This guide delivers actionable workflow enhancements, spectral analytics integration, and troubleshooting strategies to maximize research outcomes using APExBIO’s high-purity Substance P.

• Sulfo-NHS-SS-Biotin: Advanced Protein Labeling for Affinity

  2026-05-26

  Sulfo-NHS-SS-Biotin is redefining reversible protein labeling and affinity purification, offering water solubility and a cleavable disulfide bond for precision workflows. Explore how this biotin disulfide N-hydroxysulfosuccinimide ester empowers dynamic proteostasis research and surface-exposed protein analysis with unprecedented flexibility.

• 25-Hydroxycholesterol Drives Immunosuppressive TAM Metabolis

  2026-05-26

  Xiao et al. reveal that 25-hydroxycholesterol (25HC) accumulation in tumor-associated macrophages (TAMs) drives immunosuppression by activating lysosomal AMPKα and inducing a metabolic shift that sustains STAT6-ARG1 signaling. This mechanistic insight informs immunometabolic intervention strategies and highlights CH25H as a checkpoint for anti-tumor immunity.

• KX2-391 Dihydrochloride: Dual-Action Assays in Oncology and

  2026-05-25

  KX2-391 dihydrochloride (Tirbanibulin dihydrochloride) stands apart as a dual mechanism Src kinase and tubulin polymerization inhibitor with validated activity in cancer, viral, and neurotoxin research. This guide delivers applied protocols, optimization strategies, and troubleshooting tips to maximize reproducibility and data quality across these domains.

• Eliminating Pollen Interference in Fluorescence Bioaerosol D

  2026-05-25

  The reference study demonstrates a machine learning-driven strategy to overcome pollen spectral interference during hazardous bioaerosol classification using excitation–emission matrix fluorescence spectroscopy. This work substantially improves the accuracy of detecting pathogenic bacteria and toxins in complex airborne mixtures, providing a methodological advance for environmental and public health monitoring.

• Evaluating Fumagillin for Control of Azumiobodo hoyamushi in

  2026-05-24

  This study systematically investigated twenty antiprotozoal agents—including Fumagillin—for their efficacy against Azumiobodo hoyamushi, the causative agent of soft tunic syndrome in edible ascidians. The findings provide evidence-based guidance for selecting candidate drugs in aquaculture disease management and highlight the translational relevance of methionine aminopeptidase-2 inhibitors.

• Cell lysis buffer for WB and IP: Powering Robust Protein Ext

  2026-05-23

  Unlock high-yield, non-denaturing protein extraction from challenging samples—animal, plant, or microbial—with Cell lysis buffer for WB and IP. Learn how optimized inhibitor cocktails and workflow tuning boost Western blot and immunoprecipitation sensitivity, especially in complex tumor microenvironment studies.

• PF-562271 HCl: Advanced FAK/Pyk2 Inhibitor Workflows in Canc

  2026-05-22

  PF-562271 HCl empowers researchers to dissect focal adhesion kinase signaling with precise, selective inhibition, offering robust tools for modeling tumor growth and metastasis. This guide translates bench-proven workflows and troubleshooting strategies into actionable, reproducible cancer research protocols.

• Vasopressin Analogues: Expanding Therapeutic and Research Ho

  2026-05-22

  The reviewed article systematically examines vasopressin and its analogues, highlighting their evolution from natural hormones to multifunctional peptide therapeutics. Key advancements include the use of lypressin acetate in diabetes insipidus and emerging antiviral applications, offering researchers new avenues for disease modeling and mechanistic studies.

• Trelagliptin Succinate Improves Insulin Resistance in Adipoc

  2026-05-21

  This study reveals that trelagliptin succinate, a DPP-4 inhibitor, enhances insulin signaling in adipocytes by upregulating the PI-3K/AKT/GLUT4 pathway. The findings clarify the mechanistic basis for its beneficial effects on glucose uptake and adipokine regulation, offering new insights into the molecular management of insulin resistance.

• Dual Mechanism Src and Tubulin Inhibition by KX2-391: Insigh

  2026-05-21

  The reference study defines KX2-391 (Tirbanibulin dihydrochloride) as a first-in-class small molecule that uniquely inhibits Src kinase through a substrate-binding site and disrupts tubulin polymerization. This dual mechanism demonstrates high selectivity, potent cellular efficacy, and translational promise for oncology and antiviral research, while challenging traditional paradigms in protein kinase inhibitor design.

• Open-Platform DLP Enables Precise 96-Well Hydrogel Printing

  2026-05-20

  The referenced study introduces a low-cost, open-platform digital light printer (OP-DLP) optimized for high-throughput hydrogel synthesis and spatial light-activation in 96-well formats. This innovation enables reproducible, customizable hydrogel fabrication and spatially precise biomolecule activation, supporting advanced cell and material studies.

• Metoprolol in Translational Research: PK Variability and Adv

  2026-05-20

  Explore Metoprolol as a selective beta1-adrenoceptor antagonist in translational research, with a focus on pharmacokinetic variability and advanced assay design. This article uniquely integrates reference-based insights and protocol guidance for cardiovascular, anti-inflammatory, and cancer biology studies.

• Phosphatase Inhibitor Cocktail (2 Tubes, 100X): Practical Us

  2026-05-19

  The Phosphatase Inhibitor Cocktail (2 Tubes, 100X) preserves protein phosphorylation during sample preparation by inhibiting a broad range of endogenous phosphatases. It is best used in workflows such as immunoblotting, kinase activity assays, and mass spectrometry where phosphorylation state integrity is essential. It is not suitable for diagnostic or medical applications.

14994 records 10/1000 page Previous Next First page 上5页 678910 下5页 Last page